Raising Money For Breakthrough Breast Cancer
Nearly 46,000 women are diagnosed with breast cancer each year in the UK.
Breast cancer is the most commonly diagnosed cancer in the UK.
1 in 9 women in the UK will develop breast cancer at some point in their lifetime.
Nearly 1,000 women die of breast cancer every month in the UK.
Around 300 men are diagnosed with breast cancer every year in the UK.
More women than ever in the UK are surviving breast cancer thanks to better awareness, better screening and better treatments.
Breakthrough supports a programme of cutting-edge biological research to reach our vision of ‘a future free from the fear of breast cancer’. Through our research, we will increase our understanding of breast cancer, leading to improvements in diagnosis, treatment, quality of life and prevention of the disease.
Breakthrough set up the UK’s first dedicated breast cancer research centre in 1999, the Breakthrough Toby Robins Breast Cancer Research Centre at The Institute of Cancer Research, housed in the Mary-Jean Mitchell Green Building, which was opened by HRH The Prince of Wales. Today, the King’s College LondonBreakthrough Research Centre houses over 120 scientists and clinicians working together in a multidisciplinary environment.
Building on the success of the Breakthrough Research Centre, we have set up three new Breakthrough Breast Cancer Research Units, in Edinburgh, King's College London and Manchester, each with a specific breast cancer focus. The new units will enable us to spread the expertise, influence and multidisciplinary ethos of our research by working with other world class scientists in the UK.
Breakthrough runs the Breakthrough Clinical Researcher Programme, which provides funding for talented clinical researchers. The dual expertise of these unique individuals is vital to bridging the gap between basic science and the clinic.
In addition to the above initiatives, Breakthrough also supports research in areas that are considered to be important to patients, and where it is recognised that greater research is needed. Breakthrough’s Complementary Therapy Research Programme is an example of this and aims to investigate the use of complementary therapies in breast cancer management in order to better inform breast cancer patients about the potential benefits and risks of using these therapies.
